Tech Company Financing Transactions

Esperance Pharmaceuticals Funding Round

Esperance Pharmaceuticals secured a $150 thousand investment round on 9/30/2009. Investors included BVM Capital.

Transaction Overview

Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$150,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
909 Fannin St. 2000
Houston, TX 77010
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Esperance Pharmaceuticalsdevelops anticancer drugsthat kill cancer cells without harming normal cells.
Profile
Esperance Pharmaceuticals LinkedIn Company Profile
Social Media
Esperance Pharmaceuticals Company Twitter Account
Company News
Esperance Pharmaceuticals News
Facebook
Esperance Pharmaceuticals on Facebook
YouTube
Esperance Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hector Alila
  Hector Alila LinkedIn Profile  Hector Alila Twitter Account  Hector Alila News  Hector Alila on Facebook
Chief Financial Officer
Clarice Motter
  Clarice Motter LinkedIn Profile  Clarice Motter Twitter Account  Clarice Motter News  Clarice Motter on Facebook
VP - R & D
Carola Leuschner
  Carola Leuschner LinkedIn Profile  Carola Leuschner Twitter Account  Carola Leuschner News  Carola Leuschner on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2009: SiBEAM venture capital transaction
Next: 9/30/2009: Beacon Capital Strategies venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary